Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00916929 · ClinicalTrials.gov registry record · NA

Detect Fluid Early From Intra-thoracic Impedance Monitoring

A NA study of Heart Failure, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
162
Enrollment target
20
Study locations

NCT00916929 is a NA study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 162 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00916929, a NA study of Heart Failure, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
162 participants
Enrollment target
20
Study locations

Study Summary

To demonstrate the safety and effectiveness of the Impedance Monitoring Feature in St Jude Medical cardiac devices.

Conditions Studied

Interventions

  • DEVICE Impedance Monitoring Feature

Study Locations (20)

Florida

  • Shands Jacksonville - Jacksonville
  • Watson Clinic Center - Lakeland
  • Orlando Heart Center - Orlando
  • Tallahassee Research Institute - Tallahassee

Arkansas

  • Arkansas Cardiology, PA - Little Rock
  • Little Rock Cardiology Clinic, PA - Little Rock

California

  • Glendale Memorial Hospital and MC - Glendale
  • Cardiac Rhythm Specialists, Inc - Northridge

Michigan

  • Cardiology Consultants of East Michigan - Flint
  • Thoracic Cardiovascular HC Found. (Sparrow Research) - Lansing

Mississippi

  • Hattiesburg Clinic - Hattiesburg
  • North Mississippi Medical Center - Tupelo

New Jersey

  • Deborah Heart and Lung Center - Browns Mills
  • Associated Cardiovascular Consultants - Cherry Hill

Alabama

  • University of Alabama at Birmingham - Birmingham

Arizona

  • Arizona Arrhythmia Research Center - Phoenix

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2009-05
Est. Completion 2012-03
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT00916929

The ClinicalTrials.gov registry entry for NCT00916929 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Impedance Monitoring Feature is the first listed.

NCT00916929 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Arkansas, California.

Frequently Asked Questions

What is clinical trial NCT00916929 about?

NCT00916929 is a clinical study titled "Detect Fluid Early From Intra-thoracic Impedance Monitoring". To demonstrate the safety and effectiveness of the Impedance Monitoring Feature in St Jude Medical cardiac devices.

What is the current status of trial NCT00916929?

This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2009-05. Estimated completion is 2012-03.

What conditions does trial NCT00916929 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT00916929?

The interventions under investigation include: Impedance Monitoring Feature (DEVICE).

Who is sponsoring clinical trial NCT00916929?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00916929 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.